Skip to main content
INVITES BIOCORE CO., LTD logo

INVITES BIOCORE CO., LTD — Investor Relations & Filings

Ticker · 216400 ISIN · KR7216400002 KO Professional, scientific and technical activities
Open in API
Filings indexed 169 across all filing types
Latest filing 2020-10-28 Investor Presentation
Country KR South Korea
Listing KO 216400

About INVITES BIOCORE CO., LTD

https://www.bio-core.com/eng/main/main.…

INVITES BIOCORE CO., LTD. is a Contract Research Organization (CRO) that provides comprehensive services to support new drug development. Established in 2001, the company partners with pharmaceutical firms, research institutes, and medical institutions. Its primary services include bioanalytical testing, central lab services, and clinical trial support. The company also specializes in genomic analysis, offering genetic and cell screening, individual genome analysis, and related services to facilitate the advancement of precision medicine and personalized healthcare.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최결과
Investor Presentation Classification · 95% confidence The document is a short, structured announcement regarding the results of an Investor Relations (IR) event held by BioCore. It provides details on the date, location, and participants, and notes that the presentation materials are available on the Korea IR Council website. Since it is a brief notification of an event and the availability of materials rather than the presentation itself, it falls under the category of a Report Publication Announcement or general regulatory filing. Given the specific nature of announcing the results of an IR event, 'RPA' is the most accurate classification.
2020-10-28 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (EGM) for the company 'BioCore'. It details the resolutions passed, specifically the appointment of directors (board members). According to the filing definitions, documents detailing the results of shareholder votes at general meetings are classified as 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2020-08-25 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the CEO (Representative Director) of BioCore. It details the outgoing and incoming directors, the reason for the change, the date of the board resolution, and the professional background of the new CEO. This falls directly under the category of board/management changes.
2020-08-25 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Extraordinary General Meeting of Shareholders' (임시주주총회 소집 통지). It contains the meeting date, location, agenda items (election of directors), and management reference materials (경영참고사항) regarding business operations. This is a standard proxy solicitation document used to inform shareholders of an upcoming meeting and request their participation/votes. In the provided taxonomy, this fits best under 'Proxy Solicitation & Information Statement'.
2020-08-07 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal regulatory filing from a Korean company (BioCore) regarding the 'Convocation of a General Meeting of Shareholders' (주주총회소집 결의). It details the date, location, and specific agenda items (election of directors) for an upcoming Extraordinary General Meeting. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of meeting details and agenda items, which falls under the 'Proxy Solicitation & Information Statement' category.
2020-08-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically an increase due to a third-party allocation capital increase) by a major shareholder (Invites Healthcare Co., Ltd.) in BioCore Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-07-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.